<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05050474755123</udiDi>
    <basicUdiDi>5050474a000679Y</basicUdiDi>
    <tradeName>HEALON DUET PRO II</tradeName>
    <deviceName>HEALON DUET PRO II</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301016</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:40.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>05050474755109</udiDi>
    <basicUdiDi>5050474a000669W</basicUdiDi>
    <tradeName>HEALON ENDOCOAT PRO</tradeName>
    <deviceName>HEALON ENDOCOAT PRO</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301012</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:39.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000044XT</udiDi>
    <basicUdiDi>B-SEMF000017467000044XT</basicUdiDi>
    <tradeName>D-SEMF000017467000044XT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10271016</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:54.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000043XR</udiDi>
    <basicUdiDi>B-SEMF000017467000043XR</basicUdiDi>
    <tradeName>D-SEMF000017467000043XR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:53.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000042XP</udiDi>
    <basicUdiDi>B-SEMF000017467000042XP</basicUdiDi>
    <tradeName>D-SEMF000017467000042XP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10311015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:50.943Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000041XM</udiDi>
    <basicUdiDi>B-SEMF000017467000041XM</basicUdiDi>
    <tradeName>D-SEMF000017467000041XM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:49.342Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000040XK</udiDi>
    <basicUdiDi>B-SEMF000017467000040XK</basicUdiDi>
    <tradeName>D-SEMF000017467000040XK</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10292015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:48.536Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000039Y2</udiDi>
    <basicUdiDi>B-SEMF000017467000039Y2</basicUdiDi>
    <tradeName>D-SEMF000017467000039Y2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10291015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:46.933Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000038XY</udiDi>
    <basicUdiDi>B-SEMF000017467000038XY</basicUdiDi>
    <tradeName>D-SEMF000017467000038XY</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10290015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:44.542Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000037XW</udiDi>
    <basicUdiDi>B-SEMF000017467000037XW</basicUdiDi>
    <tradeName>D-SEMF000017467000037XW</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10272015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:42.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000024XM</udiDi>
    <basicUdiDi>B-SEMF000017467000024XM</basicUdiDi>
    <tradeName>D-SEMF000017467000024XM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10290014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:42.140Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000036XU</udiDi>
    <basicUdiDi>B-SEMF000017467000036XU</basicUdiDi>
    <tradeName>D-SEMF000017467000036XU</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10271015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:40.808Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000035XS</udiDi>
    <basicUdiDi>B-SEMF000017467000035XS</basicUdiDi>
    <tradeName>D-SEMF000017467000035XS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>10270015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:39.775Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000034XQ</udiDi>
    <basicUdiDi>B-SEMF000017467000034XQ</basicUdiDi>
    <tradeName>D-SEMF000017467000034XQ</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:35.736Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000033XN</udiDi>
    <basicUdiDi>B-SEMF000017467000033XN</basicUdiDi>
    <tradeName>D-SEMF000017467000033XN</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10332014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:34.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000032XL</udiDi>
    <basicUdiDi>B-SEMF000017467000032XL</basicUdiDi>
    <tradeName>D-SEMF000017467000032XL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:34.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000031XJ</udiDi>
    <basicUdiDi>B-SEMF000017467000031XJ</basicUdiDi>
    <tradeName>D-SEMF000017467000031XJ</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10311014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:30.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000030XG</udiDi>
    <basicUdiDi>B-SEMF000017467000030XG</basicUdiDi>
    <tradeName>D-SEMF000017467000030XG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10331014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:30.137Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000029XX</udiDi>
    <basicUdiDi>B-SEMF000017467000029XX</basicUdiDi>
    <tradeName>D-SEMF000017467000029XX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10322014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:29.325Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000028XV</udiDi>
    <basicUdiDi>B-SEMF000017467000028XV</basicUdiDi>
    <tradeName>D-SEMF000017467000028XV</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10330014</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:26.121Z</lastUpdated>
  </row>
</eudamedExport>